Cure My Disease

Don't miss your cure!

 Log in / Sign up

New tool to measure steroid impact on Kids' lives

NCT ID NCT07350395

Knowledge-focused Sponsor: University of the West of England Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is developing a patient-reported outcome measure (PROM) to assess how steroids affect the quality of life of children and young people with rheumatic conditions. Researchers will hold focus groups and interviews with 70 participants and their families to create and test the questionnaire. The goal is to better capture the real-world impact of steroid treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
glucocorticoids (steroids)
What this could lead to
If successful, this could lead to a new tool that helps doctors and families better understand and manage the side effects of steroids in children with rheumatic conditions.
What could go wrong
This is an early-stage study focused on developing a questionnaire, not testing a treatment. The results may not lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Three NHS sites (paediatric rheumatology clinics) will be used for recruitment of participants: Bristol Royal Hospital for Children Alder Hey Children's Hospital (Liverpool) Royal Hospital for Children (Glasgow)

Ages

Up to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 1\. Rheumatology patients aged 0 to18 years old. 2. Patients should have capacity to assent or consent immediately prior to the interview. 3\. The patient should have a good understanding of spoken and written English be able to understand the participant information sheets, assent/consent forms. 4\. Treatment with glucocorticoids with intravenous or oral glucocorticoids for an autoimmune or inflammatory condition within the previous two years (or longer duration). Parents/guardians: 1. Parents (mother/ father) or legal guardians of rheumatological patients fulfilling criteria 1-4 above. 2. Parents or legal guardians should have capacity to consent for themselves (+/- their child) immediately prior to the interview. 3. The parents or legal guardians should have a good understanding of spoken and written English be able to understand the participant information sheets, assent/consent forms. Exclusion Criteria: * 1\. Rheumatology patients who are more than 18 years of age. 2. Patients who do not have capacity to assent or consent immediately prior to the interview. 3\. Patient who have insufficient understanding of spoken and written English be able to understand the participant information sheets, assent/consent forms. 4\. Patients who either have never taken steroids or have not taken steroids within the last two years as part of their treatment plan for their rheumatological condition. 5\. Relative is not a parent or legal guardian. 6. Parents/guardians of rheumatology patients fulfilling any of the exclusion criteria above. 7\. Parents/guardians who do not have capacity to assent or consent immediately prior to the interview. 8\. Parents/guardians who have insufficient understanding of spoken and written English be able to understand the participant information sheets, assent/consent forms. 9\. Parents/guardians of rheumatology patients who have never taken steroids or have not taken steroids within the last two years as part of their treatment plan for their rheumatological condition. 10\. Membership of the steering committee

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rheumatic diseases are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rheumatic disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Rheumatic diseases Rheumatic disorder Rheumatologic conditions (jra,lupus)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Alder Hey Hospital

    RECRUITING

    Liverpool, North Somerset, L12 2AP, United Kingdom

  • Bristol Royal Hospital for Children

    RECRUITING

    Bristol, North Somerset, BS2 8BJ, United Kingdom

  • Royal Hospital for children Glasgow

    RECRUITING

    Glasgow, North Somerset, G51 4TF, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.